Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders

Recruiting · NCT06788119 · Interventional (participants receive a specific treatment) · Lead sponsor: Universitat Jaume I

View the official record on ClinicalTrials.gov →

Anxiety Alzheimer's disease

Interventions studied

Cognitive behavioral therapy with in vivo exposureCognitive behavorial therapy with in vivo exposure plus SYMPTOMS-JIT

What this trial is about

The aim of this study is to develop and test the efficacy of first-of-its-kind, fully instrumented sensor-based smartphone-guided in-vivo exposure therapy using a just-in-time intervention for anxiety disorder. The main hypotheses are: 1. Both treatment conditions (CBT treatment with IVE and CBT treatment with IVE+SYMPTOMS-JIT) will show efficacy and no statistically significant differences will be found between them. The efficacy will be determined for the differences in pre-post treatment in the used outcome measures. 2. The therapeutic gains obtained in both treatment conditions (IVE and (IVE+SYMPTOMS-JIT) will be maintained at 1-, 6-, and 12-month follow-up periods. 3. Both treatment conditions will be efficient, that is, they will be well-valued by patients and therapists. However, IVE+SYMPTOMS-JIT will be preferred and perceived as less aversive than IVE. 4. The main barriers for the use of this technology are not technological, but rather attitudinal and they can be identified through qualitative studies.

Who can take part

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not applicable (e.g. observational or device study)

Study type

Interventional (participants receive a specific treatment)

Inclusion criteria

Being at least 18 years or older.
Meeting DSM-5 diagnostic criteria (APA, 2013) for anxiety disorder, specifically specific phobia, agoraphobia, panic disorder and social phobia.
Being willing to follow the study conditions.
Sign the consent form.

Exclusion criteria

Having another psychological problem that requires immediate attention.
Having current alcohol or drug dependence or abuse, psychosis or severe organic illness.
Currently being treated in a similar treatment program.
Taking anxiolytics during the study (or in the case of taking them, changing drug or dose during the study).

Where it is running

1 location listed.

University Jaume I - Castellon, Castellón, Spain

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →